DSIP · Research brief

DSIP Benefits — What Sleep Peptide Research Reports

Real Peptides Research TeamEditorial

Updated September 16, 202610 min read

58 WORDS

Short answer

DSIP is named after the one effect it has never reliably reproduced. Schoenenberger and Monnier isolated the nonapeptide at the University of Bern in 1977, from the cerebral venous blood of rabbits during electrically induced sleep, and the delta-wave finding that gave the peptide its name has been the hardest part of the file to replicate ever since.

Key takeaways

DSIP is a nine-amino-acid peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) of roughly 850 daltons, isolated at the University of Bern in 1977 from rabbit cerebral venous blood.
The reported DSIP benefits span sleep architecture, HPA-axis stress modulation and withdrawal research, with the evidence strongest in animal EEG models and weakest in human replication.
No DSIP receptor has been definitively characterized, so the literature describes the peptide as a modulator rather than an agonist at a known target.
Research suggests DSIP is degraded by plasma peptidases within minutes, which plausibly explains much of the variability across published studies.
The tryptophan at position one enables UV quantification at 280 nm and simultaneously makes the peptide photo-oxidation-prone, so light protection matters more than most protocols assume.
A batch-specific certificate of analysis with a matching lot number, HPLC purity, mass-spec confirmation and net peptide content is the best single predictor of usable data.
DSIP is not an FDA-approved drug, and research-grade material is for laboratory use only, never for human or veterinary consumption.

We supply research-grade peptides to laboratories, and DSIP draws more documentation questions than almost anything else we ship. Our team fields the same three every week: what does the literature actually report, what belongs on a certificate of analysis, and why does material from two suppliers behave differently in the same assay?

What are the reported DSIP benefits?

The DSIP benefits reported in published research center on sleep architecture, stress-axis modulation and withdrawal-related studies rather than sedation. DSIP is a nine-amino-acid peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) of roughly 850 daltons with no definitively characterized receptor. Researchers evaluating it should start with the certificate of analysis, not the claim list.

Here's the misconception worth clearing first: most marketing copy treats DSIP benefits as settled outcomes, when the literature is really a patchwork of animal EEG work, small and mostly decades-old human studies, and Eastern European clinical reports that were never widely replicated. That doesn't make the peptide uninteresting. It makes sourcing and documentation the part you can actually control. This page covers what the research reports about DSIP benefits, the lab-handling quirks that come straight from the peptide's structure, how it compares with adjacent research compounds, and how to read a supplier's paperwork before you order.

Where the delta-sleep findings actually point

The sleep-related DSIP benefits described in the literature come from sleep-architecture research rather than sedative pharmacology, and that distinction changes how the data should be read. DSIP doesn't behave like a benzodiazepine, which acts through a well-mapped binding site on the GABA-A receptor. No DSIP receptor has been definitively cloned or characterized, so papers describe the peptide as a modulator of sleep regulation whose molecular target remains open.

Monnier's original rabbit work reported enhanced delta-wave (slow-wave) EEG activity after infusion, which is where the delta-sleep label comes from. Human work in the early 1980s, including studies by Schneider-Helmert, reported shortened sleep latency and improved subjective sleep quality in some poor sleepers, while other groups found little or no effect. Research also suggests the peptide is degraded quickly by plasma peptidases, on the order of minutes, which is one of the more plausible explanations for why outcomes swing so widely between species, routes and timing. That range is why DSIP benefits are better framed as observations than as effects.

So what does that leave? A reproducible signal in some animal EEG models, an inconsistent human record, and an unresolved mechanism. In our experience, the labs that get clean, interpretable data from DSIP are the ones treating those inconsistencies as the research question, instead of assuming the peptide's name already answered it. The DSIP benefits that look strongest on a product page are frequently the weakest in the source material.

The stress-axis findings and the tryptophan problem

Outside sleep, the DSIP benefits reported in research cluster around stress physiology. Rodent studies report that DSIP modulates hypothalamic-pituitary-adrenal (HPA) axis output, the cascade running from corticotropin-releasing hormone to ACTH (adrenocorticotropic hormone) to corticosterone, and several groups describe that effect as normalizing rather than simply suppressing. Related reports cover thermoregulation, markers of lipid peroxidation, and interactions with growth hormone and somatostatin signaling. Soviet-era and later Russian clinical literature examined a DSIP preparation in opioid and alcohol withdrawal; those reports exist, but they were largely not replicated in Western trials, so they belong in the hypothesis-generating column.

Now the part almost no summary of DSIP benefits mentions. DSIP carries tryptophan at position one, and that single residue shapes how you handle the material. Tryptophan absorbs strongly at 280 nm, which makes UV quantification straightforward compared with peptides that have no aromatic residue at all. The same residue is also among the most photo-oxidation-prone amino acids. A lyophilized vial left on a bench under fluorescent or window light can lose tryptophan integrity with no visible change to the powder: no clouding, no color shift, nothing an eye test catches. We've reviewed enough failed assays to say plainly that light exposure, not temperature, is the most underestimated variable in DSIP work. Amber glass, foil or a closed box costs nothing and protects the one residue your detector depends on, along with any DSIP benefits you're trying to measure.

How to judge DSIP material before you buy

The certificate of analysis decides whether reported DSIP benefits are even testable in your lab, because an uncharacterized vial makes every downstream result unattributable. A usable COA is batch-specific and carries four things: a lot number matching the vial label, an HPLC chromatogram with a stated purity percentage, mass spectrometry confirming the expected mass for the nonapeptide, and a test date. A generic PDF reused across every batch is the most common red flag in this market, and it takes ten seconds to spot once you check for the lot number.

Then there's the arithmetic nobody advertises. Lyophilized peptides are almost never pure peptide by weight. Purification leaves a counterion, commonly trifluoroacetate, plus residual water, so gross vial weight and net peptide content are not the same figure. A documentation-grade COA states net peptide content or the salt form, which lets you do your own mg-per-mL math instead of inheriting someone else's assumption.

Storage and regulatory status round it out. Lyophilized DSIP is kept frozen, dry and dark, while reconstituted solutions go to refrigeration with a short usable window. DSIP is not an FDA-approved drug, and research-grade peptides are supplied for laboratory research only, never for human or veterinary consumption. If your curiosity about DSIP benefits comes from an animal's sleep or stress problem, that conversation belongs with a licensed veterinarian, not a peptide supplier. Everything here is research education, not guidance for use in a person or an animal.

DSIP benefits compared with adjacent research peptides

Researchers screening sleep and stress pathways rarely look at DSIP in isolation. This table shows how the reported DSIP benefits sit beside three peptides that turn up in similar research programs, with the practical read in the final column.

Peptide	Structure and class	What published research reports	Common research context	Professional assessment
DSIP	Nonapeptide (WAGGDASGE), no characterized receptor	Delta-wave EEG changes in animal models, HPA-axis modulation, mixed human sleep-latency findings	Sleep architecture, stress response, withdrawal models	Genuinely interesting and poorly resolved; strong candidate for mechanism work, weak candidate for anyone wanting a settled answer
Selank	Heptapeptide, synthetic tuftsin analogue	Anxiolytic-type effects in rodent models and Russian clinical literature, reported influence on monoamine and immune signaling	Anxiety and stress-behavior research	Better-documented behavioral literature than DSIP, though nearly all of it comes from a single research tradition
Epitalon	Tetrapeptide (Ala-Glu-Asp-Gly), pineal-derived sequence	Reported effects on melatonin rhythm and telomerase activity in cell and animal studies, largely from Khavinson's group	Circadian and aging research	Narrow evidence base concentrated in one lab lineage; verify sequence identity and purity carefully
Ipamorelin	Pentapeptide, growth hormone secretagogue at the ghrelin receptor	Selective GH release in animal and early human studies without major prolactin or cortisol elevation	Growth hormone pulse and metabolic research	Clearest mechanism of the four, and a completely different research question from DSIP

What If: Sourcing and Handling Scenarios

What if my DSIP vial arrived at room temperature?

Log the arrival condition, then decide whether the shipment still supports your experiment. Lyophilized powder is considerably more stable than solution, and brief ambient exposure in transit is common and often tolerable for dry material; risk rises with duration, humidity and light exposure. Ask the supplier what stability basis supports their shipping method and whether the lot's testing reflected the same handling. If the vial arrived as a solution, or the seal or stopper looks compromised, treat the material as unqualified rather than assuming it survived.

What if the reported DSIP benefits look contradictory across papers?

Accept that as the honest state of the literature, not evidence you read the wrong studies. Species, administration route, timing relative to circadian phase, and whether EEG was scored automatically or by hand all move the result. Rapid peptidase degradation compounds every one of those differences. Compare methods sections before comparing conclusions, because two papers reporting opposite DSIP benefits frequently weren't measuring the same thing in the same window.

What if the certificate of analysis doesn't list net peptide content?

Ask for it in writing before ordering, and ask for the salt form at the same time. Without net content, your mg-per-mL calculation inherits an unknown error from counterion and residual water mass, and that error propagates into every concentration in the study. Suppliers doing proper characterization have the figure on hand. A supplier who can't produce it is telling you something useful about how the batch was tested.

What if my reconstituted solution looks cloudy or has visible particles?

Stop and treat the vial as unusable for quantitative work. Cloudiness in a peptide solution can indicate aggregation, incomplete dissolution, microbial contamination or degradation products, and none of those belong in a dataset. Record the diluent, temperature and time since reconstitution, photograph the vial, and contact the supplier with the lot number. Clear solution at the expected concentration is the baseline, not a bonus.

What if two suppliers' DSIP performs differently in the same assay?

Put the two certificates of analysis side by side before blaming biology. Purity percentage, the impurity profile sitting behind that percentage, salt form, net peptide content and residual solvent all vary between synthesis runs, and any one of them can shift an EEG or corticosterone readout. Small-batch synthesis with per-lot testing exists precisely to keep that variable narrow, which is why we test every lot rather than every product line.

The Unglamorous Truth About a 1977 Nonapeptide

Let's be direct about this: the DSIP benefits circulating in supplement-adjacent marketing run far ahead of the evidence, and anyone telling you otherwise hasn't read the primary papers. Nearly five decades after isolation, there's still no characterized receptor, no large modern human trial, and no consistent replication of the delta-wave effect that named the compound. What does exist is an intriguing, unresolved signal in animal sleep and stress models. Approach DSIP as an open research question with paperwork you can defend. Don't approach it as a conclusion.

For sequence, storage and characterization detail on the compound itself, our DSIP peptide listing and DSIP research overview go deeper than this page does, and the DSIP question archive collects the handling questions researchers send us most often. Batch documentation for every lot lives in the certificate of analysis library, the full peptide catalog shows what else we synthesize in small batches, and shipping coverage is listed on our service area page.

The most useful thing to understand about DSIP benefits is that the peptide's name has been doing the arguing for five decades. Delta Sleep-Inducing Peptide sounds like a finding. It's actually a 1977 observation in rabbits that human research never fully confirmed. Strip the name away and what remains is a small, fast-degrading nonapeptide with one light-sensitive residue and an unresolved mechanism, which is exactly the kind of compound careful characterization can still move forward. The naming was premature. The question isn't.

References

Peer-reviewed sources on DSIP indexed in PubMed, listed for research context. Real Peptides supplies DSIP for laboratory research use only.

Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models. Frontiers in pharmacology, 2024. PMID 39444618. doi:10.3389/fphar.2024.1439536
Sensing the Bactericidal and Bacteriostatic Antimicrobial Mode of Action Using Raman Deuterium Stable Isotope Probing (DSIP) in Escherichia coli. ACS omega, 2024. PMID 38854576. doi:10.1021/acsomega.4c01666
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke. Molecules (Basel, Switzerland), 2021. PMID 34500605. doi:10.3390/molecules26175173
Effect of Delta Sleep-Inducing Peptide on Functional State of Hepatocytes in Rats During Restraint Stress. Bulletin of experimental biology and medicine, 2016. PMID 26902351. doi:10.1007/s10517-016-3186-8
Delta sleep-inducing peptide and Deltaran: potential approaches to antistress protection. Neuroscience and behavioral physiology, 2008. PMID 18975104. doi:10.1007/s11055-008-9076-4
Interaction of Delta sleep-inducing peptide and valproate on metaphit audiogenic seizure model in rats. Cellular and molecular neurobiology, 2007. PMID 17957464. doi:10.1007/s10571-007-9222-5
Delta sleep-inducing peptide (DSIP): a still unresolved riddle. Journal of neurochemistry, 2006. PMID 16539679. doi:10.1111/j.1471-4159.2006.03693.x
[Interaction of delta sleep-inducing peptide and its analogues with cellular membranes: a structure-function analysis]. Bioorganicheskaia khimiia, 2006. PMID 16637289. doi:10.1134/s1068162006020087

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Sleep-related endpoints are typically measured with EEG recording and scored sleep-stage analysis in animal models, looking at delta-wave or slow-wave activity, sleep latency and sleep continuity. Stress-axis endpoints usually rely on plasma or serum assays for ACTH and corticosterone or cortisol, sometimes alongside behavioral testing. Because DSIP appears to be degraded by plasma peptidases within minutes, timing of sampling relative to administration is one of the biggest design decisions in the study.

Research-grade peptides including DSIP are sold for laboratory research use only, and buyers are expected to be researchers, institutions or labs handling them under appropriate controls. They are not sold, labeled or intended for human or veterinary consumption, and they are not dispensed as medicines. If a supplier implies otherwise, that's a compliance problem on their end, not a feature.

Pricing varies widely by vial size, purity specification, and whether the supplier does batch-specific analytical testing, so a single figure would be misleading. Material sold with per-lot HPLC and mass-spec documentation generally costs more than material shipped with a generic certificate, because that testing is a real per-batch expense. Compare cost per milligram of net peptide content rather than cost per vial, since gross vial weight includes counterion and residual water.

DSIP has not been evaluated or approved as a drug for human or animal use, so no safety profile for use in people or pets can be stated. It is supplied strictly as a research chemical for in vitro and preclinical laboratory work. Standard laboratory safety practice applies to handling the powder and solutions, and any health question about sleep or stress belongs with a licensed clinician or, for an animal, a licensed veterinarian.

They address different layers of the same broad question. The reported DSIP benefits center on sleep architecture and stress-axis modulation, measured mostly by EEG and corticosterone endpoints, while Epitalon research focuses on melatonin rhythm and pineal signaling, with much of that literature originating from Khavinson's group. DSIP is the more relevant tool for acute sleep-stage questions; Epitalon is more often used in circadian and aging models.

DSIP carries tryptophan at position one, and tryptophan is among the most photo-oxidation-prone amino acid residues. Light exposure can degrade that residue without producing any visible change in the lyophilized powder, which means a compromised vial looks identical to an intact one. Amber vials, foil wrapping or simply storing vials in a closed box removes the variable at essentially zero cost.

DSIP stands for Delta Sleep-Inducing Peptide. The name comes from the 1977 work of Schoenenberger and Monnier at the University of Bern, who isolated the nonapeptide from the cerebral venous blood of rabbits in electrically induced sleep and reported increased delta-wave EEG activity. The name reflects that original observation rather than a confirmed mechanism.

No. DSIP is not an FDA-approved drug product for any indication in humans or animals, and it has no approved labeling, dosing or route of administration. It is available as a research compound for laboratory investigation only. Any content presenting it as an approved or clinically validated therapy is misrepresenting its regulatory status.

Lyophilized DSIP is generally kept frozen, dry and protected from light, with the vial sealed until the moment of reconstitution to limit moisture uptake. Once in solution, peptides are typically refrigerated and used within a short window, because hydrolysis and aggregation proceed far faster in liquid than in dry powder. Supplier-specific storage statements on the certificate of analysis take precedence over general rules of thumb.

A usable certificate is batch-specific and includes a lot number that matches the vial label, an HPLC chromatogram with a stated purity percentage, mass spectrometry confirming the expected mass for the nonapeptide, the test date, and net peptide content or salt form. Appearance and solubility notes are common additions. A single generic document reused across multiple batches provides no real verification of the vial in your hand.

DSIP is a small, unmodified nine-residue peptide with no protective structural modifications such as D-amino acid substitution, cyclization or PEGylation, so it is an easy substrate for circulating peptidases. Research suggests degradation occurs on the order of minutes in plasma. That short window is one reason study results vary so much across routes, timing and species, and it's a live question in current DSIP research rather than a settled footnote.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA